golimumab
Appearance
English
[edit]Etymology
[edit]From [Term?] + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).
(This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.)
Pronunciation
[edit]- (General American) IPA(key): /ɡoʊˈlɪm.jəˌmæb/
Noun
[edit]golimumab (uncountable)
- (pharmacology) A genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
References
[edit]- “golimumab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.